Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Scoping Study Demonstrates Low Cost ISR Uranium Potential

Victoria Gold-Silver Exploration Update

Finlay Minerals Announces Increase in Size of Non-Brokered...

Satellite Imagery and Gold Exploration

Scoping Study Demonstrates Low Cost Potential (Replacement)

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium...